nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—HTR2A—urine—polycystic ovary syndrome	0.00414	0.142	CbGeAlD
Remoxipride—CYP2D6—urine—polycystic ovary syndrome	0.00377	0.129	CbGeAlD
Remoxipride—SIGMAR1—adrenal cortex—polycystic ovary syndrome	0.00206	0.0705	CbGeAlD
Remoxipride—SIGMAR1—endometrium—polycystic ovary syndrome	0.00184	0.063	CbGeAlD
Remoxipride—SIGMAR1—uterus—polycystic ovary syndrome	0.00169	0.058	CbGeAlD
Remoxipride—SIGMAR1—pituitary gland—polycystic ovary syndrome	0.00166	0.057	CbGeAlD
Remoxipride—SIGMAR1—adipose tissue—polycystic ovary syndrome	0.00166	0.0568	CbGeAlD
Remoxipride—SIGMAR1—adrenal gland—polycystic ovary syndrome	0.00148	0.0509	CbGeAlD
Remoxipride—SIGMAR1—female gonad—polycystic ovary syndrome	0.00138	0.0475	CbGeAlD
Remoxipride—SIGMAR1—vagina—polycystic ovary syndrome	0.00138	0.0472	CbGeAlD
Remoxipride—DRD2—pituitary gland—polycystic ovary syndrome	0.00134	0.046	CbGeAlD
Remoxipride—HTR2A—embryo—polycystic ovary syndrome	0.00134	0.0459	CbGeAlD
Remoxipride—DRD2—endocrine gland—polycystic ovary syndrome	0.00104	0.0357	CbGeAlD
Remoxipride—HTR2A—pituitary gland—polycystic ovary syndrome	0.000885	0.0304	CbGeAlD
Remoxipride—HTR2A—adrenal gland—polycystic ovary syndrome	0.000791	0.0271	CbGeAlD
Remoxipride—HTR2A—vagina—polycystic ovary syndrome	0.000733	0.0251	CbGeAlD
Remoxipride—HTR2A—endocrine gland—polycystic ovary syndrome	0.000686	0.0235	CbGeAlD
Remoxipride—CYP2D6—female gonad—polycystic ovary syndrome	0.000672	0.023	CbGeAlD
Remoxipride—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000625	0.0214	CbGeAlD
Remoxipride—DRD2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000416	0.000429	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000412	0.000425	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000412	0.000425	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00041	0.000422	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000406	0.000418	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000406	0.000418	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000406	0.000418	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000397	0.000409	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—FST—polycystic ovary syndrome	0.000396	0.000408	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000394	0.000406	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000394	0.000406	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000394	0.000406	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000393	0.000405	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000391	0.000403	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000391	0.000403	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000388	0.0004	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—LHB—polycystic ovary syndrome	0.000386	0.000398	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000386	0.000398	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000386	0.000397	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000383	0.000395	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000382	0.000393	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000379	0.000391	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000378	0.000389	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000374	0.000386	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000371	0.000382	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000368	0.000379	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000367	0.000378	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000366	0.000377	CbGpPWpGaD
Remoxipride—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000365	0.000376	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000365	0.000376	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000364	0.000375	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SCT—polycystic ovary syndrome	0.000362	0.000373	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000361	0.000372	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000358	0.000369	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000357	0.000368	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000355	0.000366	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000354	0.000364	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—FST—polycystic ovary syndrome	0.000352	0.000362	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00035	0.00036	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000349	0.00036	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000347	0.000358	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000345	0.000356	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000343	0.000353	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000339	0.00035	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000336	0.000347	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000335	0.000345	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000331	0.000341	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000331	0.000341	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000326	0.000336	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000325	0.000335	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000324	0.000334	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000323	0.000333	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000322	0.000331	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000318	0.000327	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000317	0.000327	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000314	0.000324	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000314	0.000323	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000312	0.000321	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000312	0.000321	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00031	0.000319	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000307	0.000316	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000302	0.000311	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000301	0.00031	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000299	0.000308	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000297	0.000306	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—INSR—polycystic ovary syndrome	0.000296	0.000305	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000295	0.000304	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000294	0.000303	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000293	0.000302	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000291	0.000299	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.00029	0.000298	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000289	0.000297	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000284	0.000292	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000281	0.00029	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000279	0.000288	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000279	0.000287	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000277	0.000285	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000276	0.000284	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000275	0.000283	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PGR—polycystic ovary syndrome	0.000274	0.000283	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000272	0.00028	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FST—polycystic ovary syndrome	0.000269	0.000277	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000267	0.000275	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000266	0.000274	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FST—polycystic ovary syndrome	0.000265	0.000273	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000263	0.000271	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000263	0.000271	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000263	0.00027	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000261	0.000269	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000261	0.000269	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000258	0.000266	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000257	0.000264	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000255	0.000263	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000255	0.000263	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000252	0.00026	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00025	0.000258	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000249	0.000256	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000248	0.000255	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000248	0.000255	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000246	0.000254	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000246	0.000253	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000246	0.000253	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000245	0.000252	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000244	0.000251	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000244	0.000251	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000243	0.000251	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000243	0.00025	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000242	0.000249	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.00024	0.000248	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000239	0.000246	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000237	0.000244	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000236	0.000243	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000236	0.000243	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000235	0.000242	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000231	0.000238	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000231	0.000238	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000229	0.000236	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000227	0.000234	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000227	0.000233	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000227	0.000233	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000225	0.000232	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000225	0.000232	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000225	0.000231	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000224	0.000231	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000223	0.00023	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PRL—polycystic ovary syndrome	0.000223	0.000229	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000222	0.000228	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000218	0.000225	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000216	0.000223	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000214	0.000221	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000214	0.00022	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000211	0.000217	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000211	0.000217	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000211	0.000217	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000211	0.000217	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00021	0.000216	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00021	0.000216	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000207	0.000213	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000201	0.000207	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000201	0.000207	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000199	0.000205	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000198	0.000204	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000198	0.000204	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000198	0.000204	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000196	0.000202	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000191	0.000197	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00019	0.000196	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000188	0.000194	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000188	0.000194	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000187	0.000193	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000186	0.000192	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000186	0.000192	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000185	0.000191	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000183	0.000189	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000183	0.000189	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000183	0.000189	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000179	0.000184	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000174	0.000179	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000173	0.000179	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000173	0.000179	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000173	0.000179	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000171	0.000176	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000171	0.000176	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000167	0.000172	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000166	0.000171	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000165	0.00017	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000164	0.000169	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000163	0.000168	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000163	0.000167	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000161	0.000166	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000161	0.000165	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.00016	0.000164	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000159	0.000163	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000158	0.000163	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000157	0.000161	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000155	0.000159	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—LEP—polycystic ovary syndrome	0.000153	0.000158	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000153	0.000157	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000152	0.000156	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000151	0.000156	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00015	0.000155	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000149	0.000154	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000149	0.000153	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000149	0.000153	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000146	0.00015	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000143	0.000148	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000143	0.000148	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000143	0.000147	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000141	0.000146	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000141	0.000145	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000139	0.000143	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000137	0.000141	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—LEP—polycystic ovary syndrome	0.000136	0.00014	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000133	0.000137	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000133	0.000137	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—POMC—polycystic ovary syndrome	0.000132	0.000136	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000131	0.000135	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—INS—polycystic ovary syndrome	0.000131	0.000135	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000131	0.000135	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000127	0.000131	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000127	0.000131	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000127	0.00013	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000125	0.000128	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000124	0.000128	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000122	0.000126	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000122	0.000125	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.00012	0.000124	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—POMC—polycystic ovary syndrome	0.000117	0.000121	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—INS—polycystic ovary syndrome	0.000116	0.00012	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—TH—polycystic ovary syndrome	0.000114	0.000117	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000113	0.000116	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000113	0.000116	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000111	0.000114	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000107	0.00011	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000107	0.00011	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000105	0.000108	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000104	0.000107	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000104	0.000107	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000103	0.000106	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—polycystic ovary syndrome	9.69e-05	9.99e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	9.3e-05	9.58e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	9.28e-05	9.56e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	9.15e-05	9.43e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	8.96e-05	9.23e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	8.91e-05	9.18e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	8.84e-05	9.11e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	8.81e-05	9.08e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	8.77e-05	9.03e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	8.62e-05	8.88e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—polycystic ovary syndrome	8.61e-05	8.87e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	8.61e-05	8.87e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	8.48e-05	8.73e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	8.47e-05	8.73e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	8.38e-05	8.63e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.28e-05	8.53e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.18e-05	8.43e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.05e-05	8.29e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	7.81e-05	8.05e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.35e-05	7.58e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	6.59e-05	6.79e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	6.48e-05	6.68e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	6.34e-05	6.53e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	6.25e-05	6.44e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—INS—polycystic ovary syndrome	6.21e-05	6.4e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—polycystic ovary syndrome	5.73e-05	5.9e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.63e-05	5.8e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.54e-05	5.7e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—polycystic ovary syndrome	5.09e-05	5.24e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	3.89e-05	4.01e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	3.83e-05	3.94e-05	CbGpPWpGaD
